ACONW
Aclarion IncKey Statistics
About Aclarion Inc
Aclarion Inc is a pioneering healthcare technology firm focused on revolutionizing the diagnosis and management of musculoskeletal disorders through its cutting-edge non-invasive imaging solutions. By leveraging advanced data analytics and proprietary algorithms, Aclarion effectively combines imaging and clinical data to provide actionable insights that enhance personalized care. This innovative approach not only improves patient outcomes but also streamlines clinical workflows, establishing Aclarion as a key player in the healthcare diagnostics sector. As the company advances its market expansion, it remains dedicated to meeting the dynamic needs of patients and healthcare professionals alike, delivering impactful solutions that redefine standards in medical imaging.
Fundamentals
| Revenue (TTM) | 77,880 |
| Gross Profit (TTM) | 15,070 |
| EBITDA | $-8.31M |
| Operating Margin | -14129.00% |
| Return on Equity | -45.40% |
| Return on Assets | -28.80% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $8.04 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.30% |
| Shares Outstanding | 0 |
| Float | $2.21M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding